Laser therapy may help some dogs with osteoarthritis feel more comfortable and move more easily when used alongside veterinary pain management and rehabilitation. Small clinical studies report encouraging results, but they do not establish a cure, a universal treatment schedule, or a reliable response for every dog. 

For owners considering treatment, the useful question is specific: does adding laser therapy help this dog perform everyday activities with less pain? This guide examines the canine evidence and explains how to turn that question into a monitored treatment plan.

What laser therapy can realistically offer a dog with arthritis

Osteoarthritis affects the whole joint and the way a dog uses the affected limb. Pain may be accompanied by stiffness, reduced range of motion and loss of muscle. A dog may hesitate before rising, shorten its usual walk or avoid surfaces it once crossed confidently. These changes deserve assessment rather than being dismissed as normal aging. 

Therapeutic laser treatment, often called photobiomodulation or PBM, delivers light to tissue with the aim of producing biological effects relevant to comfort and function. For canine arthritis, the clinically relevant outcomes are pain, mobility and participation in daily life. A proposed cellular mechanism is not proof of meaningful improvement in a pet.

How photobiomodulation may influence pain and function

Photobiomodulation is generally understood as a photochemical, not simply a heating, intervention. Red and near-infrared photons can be absorbed by endogenous chromophores, including mitochondrial cytochrome c oxidase, with downstream changes in cellular energy metabolism and signaling. Experimental work has linked these responses to modulation of ATP production, inflammatory signaling and other cellular processes that may be relevant to pain and tissue function. 

These mechanisms provide biological plausibility, but they do not prove that laser therapy regenerates cartilage or alters the structural course of canine osteoarthritis. Laboratory and preclinical findings should therefore be kept separate from the clinical question that matters to an individual dog: whether pain, mobility and everyday function improve to a meaningful degree.

The available clinical studies do not establish that laser therapy rebuilds an arthritic joint or reverses its structural changes. They also do not show that every laser device, wavelength combination or preset produces the same result. An improvement in walking should be interpreted as a functional outcome, not evidence of cartilage regeneration. 

What the clinical evidence actually shows

Controlled studies in elbow and hip osteoarthritis

Looney and colleagues studied 20 dogs with naturally occurring elbow osteoarthritis in a randomized, blinded, placebo-controlled trial. Eleven received active PBM and nine received sham treatment over six weeks. The active-treatment group showed greater improvement in lameness and pain-related outcomes, and more dogs could reduce NSAID use within the study's supervised medication plan. 

This supports considering PBM as an adjunct, but the small sample and joint-specific protocol limit generalization. The medication finding is not an instruction to reduce a dog's prescription after a certain number of sessions.

Alves and colleagues evaluated 20 dogs with bilateral hip osteoarthritis in a randomized, double-blinded controlled trial. The comparison involved a three-week Class IV laser course and a 21-day course of meloxicam. The investigators reported better results for several pain and function measures at selected follow-up points, with follow-up extending to 90 days. 

This was an active-comparator study, not a sham-laser trial. Its design and size do not establish that laser should replace medication in routine practice. Forty hips represented 20 dogs, not 40 independent canine patients.

Activity monitoring adds useful information

Barale and colleagues followed 23 dogs receiving six weekly laser treatments, measuring activity with accelerometers. Activity and step counts increased during the treatment period. However, the study lacked a concurrent untreated or sham-treatment group, and analgesic management formed part of clinical care. Improvement over time therefore cannot be attributed confidently to laser alone. 

The practical lesson is that movement can be measured beyond a clinic examination. The evidential limitation is equally important: an objective activity monitor does not remove bias from an uncontrolled study.

Combination studies need careful interpretation

A 2026 exploratory study compared bedinvetmab alone with bedinvetmab plus both PBM and pulsed electromagnetic field therapy. The combined approach was associated with improved analgesic outcomes, but the two-group design could not isolate the contribution of PBM. It should not be described as proof that laser alone produced the additional benefit. 

Taken together, these selected studies justify a discussion about a monitored adjunctive trial. They leave uncertainty about the size and durability of benefit, which dogs respond best and the optimal protocol. Evidence-based care means acknowledging those uncertainties while measuring the individual dog's response.

Confirm that osteoarthritis explains the problem

A dog that limps does not automatically have arthritis. The veterinarian needs to identify the painful region and consider alternative or additional causes, including joint instability, soft-tissue injury and neurological disease. History, examination and diagnostic testing when indicated establish the treatment target. 

An existing arthritis diagnosis also does not explain every new deterioration. Sudden inability to bear weight, rapidly escalating pain, a swollen joint with systemic illness, or new weakness calls for prompt veterinary reassessment rather than an automatic additional laser session.

Once OA is established, the plan should reflect the dog's clinical limitations and overall health. A dog with stiffness after rest has different needs from one struggling to rise or tolerate necessary daily movement. Staging frameworks such as COAST help organize care, but they do not generate a universal laser prescription. 

When hip dysplasia is the underlying condition, our guide to hip dysplasia in dogs explains the non-surgical management pathway.

Keep the foundations of joint pain management in place

Veterinary guidelines support a multimodal approach. Appropriate analgesia, weight optimization, adapted activity and environmental changes remain central. Laser therapy is one possible addition within that plan. 

For an overweight dog, weight management addresses a persistent burden on mobility. Rehabilitation can target strength and movement deficits, with exercises adapted to the patient's capacity. Secure footing, accessible resting areas and suitable ramps can make daily tasks less demanding. Owners should agree on manageable activity with the veterinary team rather than alternating prolonged inactivity with unusually strenuous outings. 

Medication choice requires an individual assessment, particularly when other illnesses or treatments are present. Difficulty tolerating one medication is a reason to review the analgesic plan; it is not evidence that laser alone will provide adequate pain control.

A dog that becomes more comfortable still needs an appropriate activity plan. Increased willingness to move does not establish that the joint can tolerate unrestricted running or jumping.

Set a baseline before the first treatment

A baseline makes the treatment discussion concrete. The team can combine a validated owner questionnaire, such as the Canine Brief Pain Inventory (CBPI) or Liverpool Osteoarthritis in Dogs (LOAD), with examination findings and home observations. Use the same instrument and follow its scoring instructions at subsequent reviews. 

For day-to-day monitoring, choose two or three activities that matter to the dog and are safe to observe. The following examples are a practical recording framework, not a validated scoring system or a challenge the dog must complete.

Daily activity	Record consistently
Rising from a usual bed	Effort, hesitation and assistance needed after a similar rest period.
An agreed short walk	Willingness, pauses and comfort afterward on a comparable route.
Moving around the home	Confidence on safe flooring and access to food or a resting area.
Resting overnight	Difficulty settling, repeated repositioning or disrupted sleep.

Short videos can help the clinician compare the same activity over time. Avoid provoking pain to produce a recording. Note medication changes, unusual exercise, illness and missed sessions so that improvement or deterioration has context.

Decide how treatment will be reviewed

Before beginning, agree on the treatment objective, a review point and what would justify continuing. The review interval should follow the chosen clinical protocol and the dog's needs; the schedules used in small trials are not universal instructions.

A practical review can consider three patterns. If the dog shows a repeatable improvement in its agreed activities, tolerates visits and has no new concerns, the veterinarian can discuss continuing or adjusting the interval. If the change is uncertain, review the records, delivery method, concurrent care and diagnosis before committing to an open-ended course. If function worsens or new signs appear, reassess promptly rather than increasing treatment automatically.

This is a decision framework, not a formally validated laser-response algorithm. Its purpose is to make continuation depend on a defensible benefit. A single energetic afternoon is weaker evidence than a consistent improvement across repeated observations.

Where pain control permits, keeping the rest of the plan reasonably consistent can help interpretation. Necessary treatment must never be withheld simply to test whether laser is working. When several interventions change together, describe the result as an improvement under the combined plan.

Maintenance also needs a reason. If sessions become farther apart, record whether function remains stable. Recurring discomfort may justify revisiting the entire plan; it does not by itself prove that indefinite laser treatment is required.

What owners should know about delivery and safety

A canine arthritis protocol must account for the target joint, treatment field, device and application method. Copying a wattage or energy figure from a paper leaves out much of the intervention. The clinic should be able to explain its choice and record what was delivered. For the technical background, see our veterinary laser therapy dosage guide.

Treatment should be performed by trained personnel using appropriate laser controls and wavelength-specific eye protection. Patient behavior and tissue heating require attention during delivery, particularly with higher-output systems. Pulling away, distress or unexpected warmth should prompt a pause and reassessment. Non-invasive does not mean risk-free.

Tell the team about other medical conditions, skin changes and any suspected or diagnosed tumor near the proposed treatment area. Suitability must be assessed before irradiation. Further precautions are covered in our veterinary laser therapy safety guide.

The studies discussed here do not validate a particular AILUCS preset or prove superiority of a multi-wavelength system. Clinics evaluating the AILUCS LYRA veterinary laser system should distinguish product capabilities from clinical evidence for a specific OA protocol.

Questions owners commonly ask

Can laser therapy replace arthritis medication

It should not be assumed to. Some research reports reduced medication requirements under supervision, but medication changes must be directed by the veterinarian. Comfort during one visit is not sufficient evidence to stop treatment. 

Can a dog with severe arthritis still be considered

Possibly, as part of an individualized plan. The relevant questions are whether pain is adequately controlled, whether another intervention is needed and whether a monitored adjunct offers worthwhile benefit. Severe functional difficulty calls for a broader review, not a promise that more laser sessions will solve it.

How quickly should an improvement appear

There is no dependable deadline for every dog. Published protocols and assessment times differ. Agree on a review point before starting, and contact the clinic earlier for deterioration. Do not use an advertised session count as a guarantee.

Is this the same as rehabilitation after TPLO surgery

No. A dog may have OA after cruciate disease, but postoperative recovery also involves surgical restrictions and healing milestones. Follow the surgeon's plan; our guide to laser therapy after TPLO surgery addresses that separate setting.

What if my dog dislikes repeated clinic visits

Include handling tolerance, travel and recovery after appointments in the decision. A small or uncertain gain may not justify a stressful routine. Discuss delivery options and other ways to meet the same comfort and mobility goals.

Make everyday function the measure of value

Laser therapy has a potential adjunctive role in canine OA, supported by a limited clinical evidence base. A useful treatment plan starts with a confirmed diagnosis, preserves established pain management and defines what improvement would look like at home. Continue because the dog demonstrates a worthwhile, tolerable benefit, and reassess when that benefit is absent or unclear.

Veterinary information notice: This article is educational and does not provide a treatment prescription. Diagnosis, medication changes and laser protocols require assessment by the treating veterinarian.

References

1. Looney AL, Huntingford JL, Blaeser LL, Mann S. A randomized blind placebo-controlled trial investigating the effects of photobiomodulation therapy (PBMT) on canine elbow osteoarthritis. Canadian Veterinary Journal. 2018;59(9):959–966.

https://pubmed.ncbi.nlm.nih.gov/30197438/

2. Alves JC, Santos A, Jorge P, Carreira LM. A randomized double-blinded controlled trial on the effects of photobiomodulation therapy in dogs with osteoarthritis. American Journal of Veterinary Research. 2022;83(8):ajvr.22.03.0036.

https://doi.org/10.2460/ajvr.22.03.0036

3. Barale L, Monticelli P, Adami C. Effects of low-level laser therapy on impaired mobility in dogs with naturally occurring osteoarthritis. Veterinary Medicine and Science. 2023;9(2):653–659. Published online November 15, 2022.

https://doi.org/10.1002/vms3.997

4. Cachon T, et al. COAST Development Group’s international consensus guidelines for the treatment of canine osteoarthritis. Frontiers in Veterinary Science. 2023;10:1137888.

https://doi.org/10.3389/fvets.2023.1137888

5. Gruen ME, et al. 2022 AAHA Pain Management Guidelines for Dogs and Cats. Journal of the American Animal Hospital Association. 2022;58(2):55–76.

https://doi.org/10.5326/JAAHA-MS-7292

6. AAHA. Chronic Pain Assessment in Dogs. Companion resource to the 2022 AAHA Pain Management Guidelines.

https://www.aaha.org/resources/2022-aaha-pain-management-guidelines-for-dogs-and-cats/chronic-pain-assessment-in-dogs/

7. Cidral LO, et al. Bedinvetmab, alone or in combination with photobiomodulation and pulsed electromagnetic field therapy, on pain and quality of life in dogs with hip osteoarthritis. Veterinary Research Communications. 2026.

https://doi.org/10.1007/s11259-026-11133-3

8. Zhang R, Qu J. The Mechanisms and Efficacy of Photobiomodulation Therapy for Arthritis: A Comprehensive Review. International Journal of Molecular Sciences. 2023;24(18):14293.

https://doi.org/10.3390/ijms241814293